Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enox Biopharma Inc (N/A) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enox Biopharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1424860.
Total stock buying since 2010: $462,016.
Total stock sales since 2010: $0.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 1,256,732 | $462,016 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-11 | 1,005,610 | $301,680 | 0 | $0 | 0 | $0 |
| 2010-08 | 50,000 | $100,000 | 0 | $0 | 0 | $0 |
| 2010-07 | 201,122 | $60,336 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-11-04 | David Itamar (Chief Financial Officer) | Buy | 603,366 | .30 | 181,008 |
| 2010-08-12 | David Itamar (Chief Financial Officer) | Buy | 25,000 | 2.00 | 50,000 |
| 2010-08-12 | Avniel Amir (Chairman of the Board) | Buy | 25,000 | 2.00 | 50,000 |
| 2010-07-15 | David Itamar (Chief Financial Officer) | Buy | 201,122 | .30 | 60,336 |
Insider trading activities including stock purchases, stock sales, and option exercises of N/A listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enox Biopharma Inc (symbol N/A, CIK number 1424860) see the Securities and Exchange Commission (SEC) website.